SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending amid a sharp intraday reversal, prompting discussions about potential market manipulation and the strength of the AI sector following Nvidia's earnings; traders are actively debating whether this pullback represents a buying opportunity or the start of a deeper correction, with some pointing to possible Yen carry trade issues.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is experiencing volatility, sparking debates about a potential market bottom and the influence of large institutional players. Community discussions revolve around whether this dip presents a buying opportunity or signals a deeper correction, with some pointing to macro factors and potential liquidations as drivers. Sentiment is mixed, with bullish and bearish arguments clashing amidst the price swings.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia's stock is trending amid upgrades from analysts, though some community members express concern over valuation relative to competitors and potential interconnect hurdles in the AI sector. Despite strong earnings, the stock experienced a selloff, leading to discussions about a possible short squeeze and whether AI constitutes a bubble.

SSgA Active Trust - SPDR S&P 500 ETF Trust

SPY is experiencing heavy volatility, sparking discussions about a potential market correction and whether dip-buying strategies will continue to pay off. Some community members are pointing to broader macroeconomic concerns and the influence of crypto markets, while others are eyeing key support levels for potential reversals. The conversation highlights uncertainty around near-term market direction.

Walmart, Inc. engages in the retail and wholesale business. The company offers an assortment of merchandise and services at everyday low prices. It operates through the following business segments: Walmart U.S., Walmart International, and Sam's Club. The Walmart U.S. segment operates as a mass merchandiser of consumer products, operating under the Walmart and Walmart Neighborhood Market brands, including walmart.com. The Walmart International segment includes operations of wholly-owned subsidiaries in Canada, Chile, China, and Africa, and majority-owned subsidiaries in India, as well as Mexico and Central America. The Sam's Club segment manages membership-only warehouse clubs and operates samsclub.com. The company was founded by Samuel Moore Walton and James Lawrence Walton on July 2, 1962 and is headquartered in Bentonville, AR.

Walmart Inc

Walmart is trending due to strong Q3 earnings and raised FY26 guidance, sparking bullish sentiment among investors; discussions include the impact of e-commerce growth and a planned move to the Nasdaq. Community members are debating whether Walmart's performance signals broader economic strength or if it's a safe haven during market uncertainty, while also pondering its valuation relative to tech companies.

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending downwards, frustrating investors who cite strong deliveries and question the stock's valuation relative to peers. Community members speculate about market manipulation and potential short squeezes while bracing for upcoming earnings. Despite the negative price action, some investors remain optimistic, viewing the current dip as a buying opportunity based on the company's long-term potential.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategy is trending as the price of Bitcoin fluctuates, impacting MicroStrategy's value as a major BTC holder; the community is closely watching key support levels. Discussions revolve around analyst Tom Lee's commentary and potential short squeezes, with some expressing concerns about solvency and potential liquidation. Recent whale activity and overall market sentiment add to the volatility.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares

SOXL is trending as traders assess its volatile movements amidst optimism in the AI sector. Community discussions revolve around dip-buying strategies and potential profit-taking points, especially with upcoming earnings from key semiconductor players like NVDA. The ongoing government shutdown and concerns about AI valuations add to the uncertainty surrounding this leveraged ETF.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is trending following a target price increase from UBS and rising memory prices linked to AI data-center demand, fueling discussions about its growth potential. Community members are weighing the bullish outlook against concerns of an overbought condition after the stock's significant year-to-date gains. Discussions also focus on potential short-term pullbacks versus long-term opportunities in the semiconductor space.

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is trending amidst overall crypto market volatility and the launch of new ETFs, sparking debates on their potential impact. Community discussions revolve around whether XRP can decouple from Bitcoin's influence and the significance of upcoming ISO20022 compliance. Some traders express frustration with price stagnation, while others remain optimistic about long-term utility and institutional adoption.

statis crypto Watchlist

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

These five biotech stocks, all belonging to nano-, small- or mid-cap categories, notched the highest jump in Stocktwits message volume in the week ended Feb. 14, 2025:GlycoMimetics Inc. (+550% jump in chatter)GlycoMimetics, a late-stage biotech firm developing glycobiology-based cancer therapies, saw a surge in retail interest after a minor amendment to its merger agreement with Crescent Biopharma. The update refined the financing structure but kept intact the exchange ratio and ownership split. Once the deal closes, Crescent security holders, including new investors, will own about 96.9% of the combined company. Shares are up roughly 16% year-to-date (YTD).GRAIL Inc. (+500% jump in chatter)Cancer detection firm GRAIL made waves after announcing a partnership with Quest Diagnostics (DGX) to distribute its Galleri multi-cancer early detection test. Analysts at Guggenheim viewed the move as a major step toward broader accessibility. The stock has soared over 208% YTD.ADMA Biologics Inc. (+400% jump in chatter)ADMA Biologics, a biopharma company focused on plasma-derived therapies, saw rising buzz ahead of its upcoming fourth-quarter (Q4) earnings. Last month, it issued a preliminary report projecting full-year 2024 revenue between $417 million and $425 million, with total cash holdings exceeding $100 million. Despite the strong forecast, shares remain down more than 8% YTD.Moleculin Biotech Inc. (+295% jump in chatter)Moleculin Biotech gained traction after the FDA provided guidance on its Phase 3 trial for Annamycin, a next-generation anthracycline designed to treat relapsed/refractory acute myeloid leukemia (AML) and soft tissue sarcoma lung metastases. With an adjusted trial size, the company expects its first unblinding in late 2025 and another in early 2026. Shares have climbed over 25% YTD.Exelixis Inc. (+200% jump in chatter)Exelixis, an oncology-focused biotech, saw a surge in discussions after reporting Q4 earnings that topped estimates, prompting analysts to raise their price targets. Citi highlighted continued strength in its Cabometyx franchise and pointed to Zanza as a potential blockbuster drug. Shares are up 4.35% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Hand holding test tube over stock data on computer monitor. | Image source: Getty Images

Top 5 Biotech Stocks That Got Most Retail Buzz Last Week

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.

Equity

From merger updates to earnings surprises, these healthcare stocks saw the biggest spike in Stocktwits chatter.


Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024

Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 Crescent Biopharma to Present at Jefferies London Healthcare Conference 2024 PR Newswire WALTHAM, Mass., Nov. 12, 2024...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ZUO, PFIE, GLYC on Behalf of Shareholders...

GlycoMimetics Announces New Uproleselan Clinical Data Will Be Presented at ASH Annual Meeting

GlycoMimetics, Inc. (Nasdaq: GLYC) today announced that data from multiple clinical trials studying uproleselan in patients with acute myeloid leukemia (AML) have been accepted for presentation at...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ALTR, PFIE, GLYC on Behalf of Shareholders...

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC

INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc. - GLYC INVESTIGATION ALERT: The M&A Class Action Firm Investigates the Merger of GlycoMimetics, Inc...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates USAP, ALTR, GLYC on Behalf of Shareholders...

GLYCOMIMETICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of GlycoMimetics, Inc. - GLYC

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed merger of GlycoMimetics, Inc. (NasdaqGM: GLYC) and...

Integrated Media Technology Limited (<a class="mention" data-mention="$IMTE" data-symbol-id="IMTE" href="https://stocktwits.com/symbol/IMTE" target="_blank">$IMTE</a>)IMTE stock rose 5% pre-market on Wednesday, building on a 9.39% rise to close at $1.98 in the previous session.The uptick in share price comes after the company appointed Zhiyun Tan to its board of directors. Tan has over a decade of experience in business and tax advisory services. According to the tech company, Tan’s addition to the board will bolster its advisory capabilities.<figure class="image"><img style="aspect-ratio:1279/286;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_064506_eab9455f6b.png" alt="Screenshot 2024-10-30 064506.png" width="1279" height="286"><figcaption>IMTE's Sentiment and Message Volume on Oct 30 as of 6:45 a.m. ET | Source: Stocktwits</figcaption></figure>Stocktwits retail sentiment skyrocketed to ‘extremely bullish’ (97/100), its highest mark this year, as message volume hit a one-year peak at ‘extremely high’ (95/100).The stock has lost 23% of its value so far in 2024.GlycoMimetics Inc. (<a class="mention" data-mention="$GLYC" data-symbol-id="GLYC" href="https://stocktwits.com/symbol/GLYC" target="_blank">$GLYC</a>)GlycoMimetics shares fell 16% pre-market Wednesday, following a massive 191% surge in the prior trading session, after announcing its acquisition of Crescent BioPharma, an oncology therapeutics developer focused on solid tumors.The merger has received approval from the boards of both companies, though closing remains contingent on stockholder approval and other customary conditions, with finalization expected by Q2 2025.Upon completion, GlycoMimetics plans to adopt Crescent Biopharma as its new name, marking a significant pivot in its strategic focus.<figure class="image"><img style="aspect-ratio:1280/282;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_065931_7a6c00f4c3.png" alt="Screenshot 2024-10-30 065931.png" width="1280" height="282"><figcaption>GlycoMimetics' Sentiment and Message Volume on Oct 30 as of 6:59 a.m. ET | Source: Stocktwits</figcaption></figure> Retail sentiment on Stocktwits has peaked for a second time this year to ‘extremely bullish’ (97/100) with ‘extremely high’ (97/100) message volume.GlycoMimetics’ stock has dipped 85% so far this year.Alphabet Inc. (<a class="mention" data-mention="$GOOG" data-symbol-id="GOOG" href="https://stocktwits.com/symbol/GOOG" target="_blank">$GOOG</a>)Shares of Google-parent Alphabet rose nearly 7% pre-market Wednesday, following a 1.2% gain in the prior session, after reporting strong quarterly earnings post-market close.Alphabet posted revenue of $88.27 billion, surpassing analysts’ expectations of $86.39 billion, and earnings of $2.12 per share, topping Wall Street’s forecast of $1.84 per share.The earnings report highlighted a historic milestone for Google-owned YouTube, which generated $50 billion in revenue for the first time.<figure class="image"><img style="aspect-ratio:1277/282;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_30_071149_0e8d6e2f5c.png" alt="Screenshot 2024-10-30 071149.png" width="1277" height="282"><figcaption>Alphabet's Sentiment and Message Volume on Oct 30 as of 7:11 a.m. ET | Source: Stocktwits</figcaption></figure>Retail sentiment around the stock remains in the ‘extremely bullish’ (92/100) territory with an uptick in chatter to ‘extremely high’ (87/100) amid the earnings buzz.Google’s stock has gained 31% so far in 2024.For updates and corrections email newsroom@stocktwits.com.Read more: <a href="https://stocktwits.com/news-articles/markets/equity/glw-stock-makes-retail-more-bullish-after-q3-earnings/cJ2DsSpRJw">Corning Stock Boosts Retail Bullishness As Wall Street Analysts Raise Price Targets Post Q3 Earnings</a> &nbsp;

Google is among the top 3 most bullish stocks on Stocktwits today

Alphabet, Integrated Media, GlycoMimetic: 3 Stocks Making Retail Most Bullish Pre-Market Today

Retail sentiment is bullish on all three stocks, driven by Google's impressive financial performance, GlycoMimetics' announcement of a merger and potential rebranding, and IMTE's recent board strengthening.

Integrated Media, GlycoMimetic, Alphabet: 3 Stocks Making Retail Most Bullish Pre-Market Today

GlycoMimetics Inc. (<a class="mention" data-mention="$GLYC" data-symbol-id="GLYC" href="https://stocktwits.com/symbol/GLYC" target="_blank">$GLYC</a>)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/GLYC_sentiment_and_message_volume_Oct_29_2d5d960690.png" alt="GLYC sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Shares of GlycoMimetics surged over 200% on Tuesday, making it the top gainer across U.S. markets and reaching a near two-year high. The biotech firm’s rally follows news of its <a href="https://stocktwits.com/news-articles/markets/equity/glyc-stock-surges-on-acquisition-deal/cJ2uwL4RJq">acquisition agreement</a> with Crescent Biopharma, backed by a $200 million investment commitment from investors including Fairmount, Venrock Healthcare Capital, and BVF Partners.&nbsp;The combined company will operate under the Crescent Biopharma name. Retail sentiment on Stocktwits skyrocketed, shifting to “extremely bullish” (97/100) from “neutral” on Monday.Canaan Inc. ($CAN)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/CAN_sentiment_and_message_volume_Oct_29_41df60828f.png" alt="CAN sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Shares of Canaan Inc., a company focused on Bitcoin mining technology, surged nearly 20% to a three-month high on Tuesday as Bitcoin’s price reached a peak of $72,338 — its highest level since April.&nbsp;This Bitcoin surge fueled significant retail interest, causing Canaan’s Stocktwits sentiment score to jump to “extremely bullish” (97/100) from a previous “bearish” outlook.PayPal Holdings Inc. ($PYPL)<figure class="image"><img style="aspect-ratio:1318/314;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/PYPL_sentiment_and_message_volume_Oct_29_7f56a8c668.png" alt="PYPL sentiment and message volume Oct 29.png" width="1318" height="314"></figure>Despite a 3% dip following its <a href="https://stocktwits.com/news-articles/markets/equity/paypal-stock-plummets-mixed-earnings-retail-investors-bullish/cJ2un8iRJm?source_caller=ui&amp;shortlink=sefos10f&amp;pid=ds&amp;af_click_lookback=7d&amp;af_xp=custom">Q3 earnings</a> report on Tuesday, which missed revenue expectations, PayPal saw a wave of retail optimism. The earnings report did exceed profit expectations, and management’s optimistic outlook reassured many investors, lifting Stocktwits sentiment to ‘extremely bullish’ (96/100).&nbsp;The divergence between sentiment and price suggests retail investors are focusing on PayPal’s long-term potential over short-term volatility.For updates and corrections, email&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="mailto:newsroom@stocktwits.com">newsroom@stocktwits.com</a>Read next: <a href="https://stocktwits.com/news-articles/markets/equity/tmtg-core-civic-humana-stocks-poised-for-gains-with-trump-victory-retail-sentiment-mixed/cJ2urOCRJp">TMTG, CoreCivic, Humana Stocks Poised For Gains With Trump Victory: Retail Sentiment Mixed</a>

The most bullish stock during Tuesday's mid-day trading | Source: Pixabay

GlycoMimetics, Canaan, PayPal: 3 Stocks Retail Is Most Bullish On Today

Acquisition news, Bitcoin ripping higher and management’s confident commentary despite a post-earnings dip are fueling a lot of optimism 

Crescent Biopharma, Inc. operates as a biopharmaceutical company that develops and designs small molecule therapeutics to treat cancers. The company was founded on September 19, 2024 and is headquartered in Waltham, MA.

GLYC
GlycoMimetics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest GLYC News

GLYCGlycoMimetics Inc